In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

For decades, weight loss drugs have tried to coax the body into burning more energy, but the most aggressive approaches have ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most ...

MIAMI, Jan. 08, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today ...

A class of ultrasmall fluorescent core-shell silica nanoparticles developed at Cornell is showing an unexpected ability to rally the immune system against melanoma and dramatically improve the ...

Detailed price information for Ernexa Therapeutics Inc (ERNA-Q) from The Globe and Mail including charting and trades.

The global cancer drugs market is surging toward $594.3 billion by 2035 as high-tech immunotherapies begin to replace ...

Japanese scientists have created miniature human brain circuits by joining lab-grown thalamus and cortex models from stem ...

An Abuja-based medical expert, Dr Maryam Ahmed Almustapha, has raised an alarm over the potentially devastating effects of ...

NanoSyrinx, a synthetic biology company developing Nanosyringestm as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced the appointment of Thomas J. Farrell ...

Aspen Neuroscience, Inc., a clinical?stage biotechnology company pioneering autologous regenerative therapies, today announced two executive leadership appointments: Revati Shreeniwas, M.D., FCCP has ...